Abstract

To study the roles and association of murine double minute gene 2 (MDM2) and fructose-1,6-biphosphatase (FBP1) in human hepatocellular carcinoma (HCC), growth response of human HCC cells was assessed using proliferation and apoptosis assay. Pro-survival AKT signaling associated proteins (p-AKT, survivin and cleaved caspase 3) were assessed using western blotting. The correlation between MDM2 and FBP1 was assessed using co-immunoprecipitation combined with ubiquitination assay. Our data suggested that low expression of FBP1 was correlated with high levels of MDM2 in HCC cell lines (Huh7 and Hep3B). Overexpression of FBP1 resulted in anti-proliferation, pro-apoptosis, the up-regulation of cleaved caspase 3 while the downregulation of survivin and phosphor (p)-AKT, however, knockdown of FBP1 led to the opposite. Furthermore, overexpression of MDM2 potently reversed FBP1-induced proliferation inhibition and apoptosis, while Nutlin-3 (an MDM2 inhibitor) reversed the change trends induced by FBP1 knockdown in the aforementioned events. Lastly, but not least importantly, our data elucidated that MDM2 binds directly to FBP1 and promotes FBP1 ubiquitination. In conclusion, our data firstly suggested the involvement of FBP1 and its association with MDM2 in HCC cell growth. MDM2-FBP1-regulated HCC cell growth and the activation of AKT were mediated, at least in part, through FBP1 degradation.

Highlights

  • Due to a lack of treatment options, currently, hepatocellular carcinoma (HCC) has constituted the 5th most frequent and accounted for 3rd most lethal malignancies worldwide (Zender and Kubicka, 2008)

  • murine double minute gene 2 (MDM2) directly interacted with FBP1 and regulated FBP1 ubiquitination To study the interaction between MDM2 and FBP1 in cancer progress of HCC in vitro, lentiviral-mediated MDM2 overexpression was transfected into Huh7 and Hep3B cells, respectively

  • We studied whether MDM2 acted as an E3 ubiquitin ligase to regulate FBP1 degradation in human HCC cells

Read more

Summary

Introduction

Due to a lack of treatment options, currently, hepatocellular carcinoma (HCC) has constituted the 5th most frequent and accounted for 3rd most lethal malignancies worldwide (Zender and Kubicka, 2008). According to a reported study, HCC treatment has been focused on targeted therapy rather than systemic chemotherapy that aims to inhibit pathways which are essential for tumor growth, even in the late stages of carcinogenesis (Zender and Kubicka, 2008). Studies have shown that FBP1 may act as a co-suppressor for multiple transcription factors to reduce downstream gene expression and control various cellular processes including proliferation and apoptosis (Chen et al, 2021; Hu et al, 2021; Liu et al, 2017). Mounting studies have elucidated that FBP1 is frequently lost in HCC, and strategies to restore the levels and activities of FBP1 in tumor cells may affect cellular processes in carcinogenesis (Yang et al, 2017b)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call